Cbd Global Sciences Inc
CNSX:CBDN
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
N/A
N/A
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CAD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| CA |
C
|
Cbd Global Sciences Inc
CNSX:CBDN
|
1.5m CAD |
Loading...
|
|
| IN |
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
3.9T INR |
Loading...
|
|
| CH |
S
|
Sandoz Group AG
SIX:SDZ
|
26.8B CHF |
Loading...
|
|
| US |
|
Dupont De Nemours Inc
NYSE:DD
|
18.4B USD |
Loading...
|
|
| CN |
|
Zhejiang Nhu Co Ltd
SZSE:002001
|
85.9B CNY |
Loading...
|
|
| CN |
C
|
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
|
55.4B CNY |
Loading...
|
|
| CN |
|
Hebei Changshan Biochemical Pharmaceutical Co Ltd
SZSE:300255
|
52B CNY |
Loading...
|
|
| CN |
C
|
Changchun High & New Technology Industries Group Inc
SZSE:000661
|
40.3B CNY |
Loading...
|
|
| JP |
|
Sumitomo Pharma Co Ltd
TSE:4506
|
899.1B JPY |
Loading...
|
|
| US |
|
Balchem Corp
NASDAQ:BCPC
|
5.4B USD |
Loading...
|
|
| UK |
|
Croda International PLC
LSE:CRDA
|
3.9B GBP |
Loading...
|
Market Distribution
| Min | -4 710 029.9% |
| 30th Percentile | -65.8% |
| Median | -2.4% |
| 70th Percentile | 11% |
| Max | 71 100% |
Other Profitability Ratios
Cbd Global Sciences Inc
Glance View
Cbd Global Sciences, Inc. engages in business of producing and selling industrial hemp derived cannabidiol infused consumable and topical products. The company is headquartered in Calgary, Alberta. The company went IPO on 2019-10-29. The firm is engaged in the business of producing and selling industrial hemp derived CBD infused consumable and topical products, including but not limited to CBD oil tincture drops, CBD hydration beverages, and CBD topicals. The company markets and sells its own brand of CBD oil and byproducts under the Aethics and CannaOil brands (Products), which includes CBD Oil tinctures (liquid products), CBD capsules, CBD topicals, hydration products and confectionary products. Its hemp-derived CBD extracts are sold through distributors, brick and mortar retailers and online. The Company, through its wholly owned subsidiaries, Global Sciences Holdings, Resinosa LLC and Legacy Distribution Group, is delivering CBD products both in a retail and e-commerce formats. Its subsidiaries include Strasburg Pharms, LLC, Global NV Corp., CannaOil, Inc., SMBT, LLC, Global Sciences IP, LLC and Energy Unleased LLC, among others.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
Over the last 2 years, Cbd Global Sciences Inc’s Operating Margin has decreased from -162.1% to -610.7%. During this period, it reached a low of -2 051.1% on Jun 30, 2021 and a high of 460.9% on Dec 31, 2021.